脑部放疗，上午比下午敏感许多！
; h7 C z/ K; g" J: k7 v, {
+ x2 D9 S3 B' Z8 l& B# u( j D2 w0 H4 S$ C: w$ T8 ~
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.: w8 z( Y- U, ], M0 O M
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
1 M( R+ }3 B4 |5 z; yRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
" R9 _8 ~ v( X2 c3 x }' W* g! \3 rSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA./ F" f# |$ }! t% Y" R; r
* e3 A* ?0 y( [- H( uAbstract k. }; O. v% }; t
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.. g, @: O4 P* E3 A9 j7 F }
4 w1 U5 @8 c) U9 \- u. X
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.6 I$ }$ N s0 f& W( O7 h: D
0 v8 d2 M$ o& q$ y. V' g6 eRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).0 y/ f c/ o: V0 T
& ^; a; G. i& C3 ^ O3 p3 [CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
8 N! o8 i7 g( V3 ?9 f
* Z! O( I7 B. k; j2 Q |
. V* \+ N4 O ?( b. ?* P' U
显身卡
